
В течение несколько последних десятилетий уделяется особое внимание созданию инновационных лекарственных средств. Их внедрение в медицинскую практику повышает эффективность лечения болезней, которые ранее считались неизлечимыми, приводит к отказу от использования менее эффективных и устаревших способов терапии, сокращает период нетрудоспособности. Среди инновационных препаратов особого внимания заслуживают лекарственные формы с улучшенными фармакокинетическими показателями, а также современные системы доставки лекарственных средств к органам, тканям и клеткам-мишеням.
During the last few decades special attention is paid to the creation of innovative medicines. Their introduction into medical practice increases the effectiveness of the treatment of diseases previously considered incurable, leads to the rejection of the use of less effective and obsolete methods of therapy, reduces the period of disability. Among the innovative products medication forms with improved pharmacokinetic parameters deserve special attention, as well as modern systems of drug delivery to organs, tissues and target cells.
ИННОВАЦИОННЫЕ ЛЕКАРСТВЕННЫЕ СРЕДСТВА, ТЕРАПЕВТИЧЕСКИЕ СИСТЕМЫ, ЛИПОСОМЫ
ИННОВАЦИОННЫЕ ЛЕКАРСТВЕННЫЕ СРЕДСТВА, ТЕРАПЕВТИЧЕСКИЕ СИСТЕМЫ, ЛИПОСОМЫ
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
